Arkansas Resolution Would Increase Prescription Drug Costs
February 21, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on Arkansas Senate Resolution 9:...
Filter by:
Press Releases
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
CMS Report: PBM Tools Reduce Prescription Drug Costs
February 16, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on new National Health Expenditure (NHE) data...
PCMA Letter to the Council of Economic Advisers
February 15, 2018
The Pharmaceutical Care Management Association recently submitted a letter to the Council of Economic Advisers. Click here for the letter...
PCMA: Response to Anti-PBM Article in the American Prospect
February 14, 2018
A recent article (“The Corporate Scam that Even Trump Opposes: PBMs”) attacks the one industry that is both reducing prescription drug...
February 09, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on health care proposals reportedly included in...
PCMA Applauds Administration’s Effort to Reduce Opioid Abuse
February 02, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the Centers for Medicare and Medicaid’s...
PCMA Statement on Medicare Part D Proposed Rule
January 17, 2018
The Pharmaceutical Care Management Association (PCMA) released the following statement on recently submitted comments to the Centers for Medicare &...
Gleostine Price Hike Undercuts Drugmakers’ Campaign to Deflect Blame for High Prices
January 04, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the decision to raise Gleostine’s price...